FDA Approval for TRUDHESA issued to IMPEL NEUROPHARMA INC
$IMPL
Biotechnology: Pharmaceutical Preparations
Health Care
New Drug Application (NDA): 213436
Company: IMPEL NEUROPHARMA INC
Company: IMPEL NEUROPHARMA INC
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| TRUDHESA | DIHYDROERGOTAMINE MESYLATE | 1.45MG | SPRAY, METERED;NASAL | Prescription | None | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 09/02/2021 | ORIG-1 | Approval | Type 5 - New Formulation or New Manufacturer | STANDARD |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213436s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/213436Orig1s000ltr.pdf |
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
|---|---|---|---|---|---|
| 09/02/2021 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213436s000lbl.pdf |